US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
US8552054B2
(en)
*
|
2001-03-23 |
2013-10-08 |
Luitpold Pharmaceuticals, Inc. |
Fatty amine drug conjugates
|
BR0208627A
(pt)
*
|
2001-04-06 |
2004-03-09 |
Wyeth Corp |
Combinações antineoplásicas tal como rapamicina junto com gencitabina ou fluorouracila
|
WO2003059339A1
(en)
|
2002-01-15 |
2003-07-24 |
Trustees Of Dartmouth College |
Tricyclic-bis-enone derivatives and methods of use thereof
|
US7265096B2
(en)
|
2002-11-04 |
2007-09-04 |
Xenoport, Inc. |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
|
WO2005094358A2
(en)
*
|
2004-03-29 |
2005-10-13 |
Roswell Park Cancer Institute |
Method of treating solid tumors and leukemias using combination therapy of vitamin d and anti-metabolic nucleoside analogs
|
FR2874016B1
(fr)
*
|
2004-06-30 |
2006-11-24 |
Centre Nat Rech Scient Cnrse |
Nanoparticules de derives de la gemcitabine
|
KR100699099B1
(ko)
*
|
2004-07-29 |
2007-03-22 |
한미약품 주식회사 |
1-α-할로-2,2-다이플루오로-2-데옥시-D-라이보퓨라노스유도체 및 이의 제조방법
|
WO2006029081A2
(en)
*
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
US7691827B2
(en)
*
|
2004-12-17 |
2010-04-06 |
Eli Lilly And Company |
Amide prodrug of gemcitabine, compositions and use thereof
|
NO322682B1
(no)
*
|
2005-03-18 |
2006-11-27 |
Clavis Pharma Asa |
Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
|
KR100680765B1
(ko)
*
|
2005-04-28 |
2007-02-09 |
주식회사 삼천리제약 |
3'-아미노-2',3'-디데옥시구아노신의 제조 방법
|
NO324263B1
(no)
*
|
2005-12-08 |
2007-09-17 |
Clavis Pharma Asa |
Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
|
US8497292B2
(en)
*
|
2005-12-28 |
2013-07-30 |
Translational Therapeutics, Inc. |
Translational dysfunction based therapeutics
|
EP1994042A4
(en)
*
|
2006-02-06 |
2009-03-18 |
Reddys Lab Ltd Dr |
PREPARATION OF GEMCITABINE
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
ES2446092T3
(es)
|
2006-06-21 |
2014-03-06 |
Eli Lilly And Company |
Formas cristalinas del profármaco amida gemcitabina, composiciones y uso de las mismas
|
US8299046B2
(en)
|
2006-11-17 |
2012-10-30 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
WO2008064133A1
(en)
|
2006-11-17 |
2008-05-29 |
Trustees Of Dartmouth College |
Synthesis and biological activities of new tricyclic-bis-enones (tbes)
|
US8921340B2
(en)
|
2006-11-17 |
2014-12-30 |
Trustees Of Dartmouth College |
Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
KR100957756B1
(ko)
*
|
2007-12-12 |
2010-05-12 |
동우신테크 주식회사 |
2'-데옥시-2',2'-다이플루오로사이티딘의 제조 방법
|
US9114138B2
(en)
|
2007-09-14 |
2015-08-25 |
Janssen Pharmaceuticals, Inc. |
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
RU2488591C2
(ru)
*
|
2007-09-26 |
2013-07-27 |
Маунт Синай Скул Оф Медсин |
Аналоги азацитидина и их применение
|
ES2402138T3
(es)
*
|
2007-12-28 |
2013-04-29 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Terapia contra el cáncer con un parvovirus combinado con quimioterapia
|
WO2009089545A1
(en)
|
2008-01-11 |
2009-07-16 |
Reata Pharmaceuticals, Inc. |
Synthetic triterpenoids and methods of use in the treatment of disease
|
CA2721838C
(en)
|
2008-04-18 |
2017-05-23 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
|
CN102164941B
(zh)
|
2008-04-18 |
2015-05-27 |
里亚塔医药公司 |
抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
|
BRPI0911422B8
(pt)
|
2008-04-18 |
2021-05-25 |
Reata Pharmaceuticals Inc |
compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos
|
WO2009146216A2
(en)
|
2008-04-18 |
2009-12-03 |
Reata Pharmaceuticals. Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
MX2010011435A
(es)
|
2008-04-18 |
2011-01-25 |
Reata Pharmaceuticals Inc |
Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
|
FR2931152B1
(fr)
*
|
2008-05-16 |
2010-07-30 |
Centre Nat Rech Scient |
Nouveau systeme de transfert d'acide nucleique
|
JP5758801B2
(ja)
|
2008-07-22 |
2015-08-05 |
トラスティーズ・オブ・ダートマス・カレッジTrustees of Dartmouth College |
単環式シアノエノンおよびその使用方法説明
|
WO2010025890A1
(en)
|
2008-09-02 |
2010-03-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
WO2010039039A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Clavis Pharma Asa |
Oral formulations of gemcitabine derivatives
|
AU2009319387B2
(en)
|
2008-11-28 |
2012-05-10 |
Addex Pharma S.A. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
CN101525361B
(zh)
|
2009-04-21 |
2010-11-17 |
济南圣鲁金药物技术开发有限公司 |
基于吉西他滨结构的前药及其合成方法及应用
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
CA2760259C
(en)
|
2009-05-12 |
2018-05-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JP5634506B2
(ja)
|
2009-05-12 |
2014-12-03 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド |
1,2,3−トリアゾロ[4,3−a]ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用
|
RU2012125350A
(ru)
*
|
2009-11-20 |
2013-12-27 |
Клавис Фарма Аса |
Парентеральные препараты производных гемцитабина
|
GB201006181D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
JP5852665B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
US9693957B2
(en)
|
2011-07-08 |
2017-07-04 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
US20130115628A1
(en)
*
|
2011-08-02 |
2013-05-09 |
Ventana Medical Systems, Inc. |
Method for selection of chemotherapeutic agents for adenocarcinoma cancer
|
CN102432654A
(zh)
*
|
2011-09-26 |
2012-05-02 |
宋云龙 |
吉西他滨酰胺衍生物及其制备方法和用途
|
CN102617679B
(zh)
*
|
2012-03-13 |
2014-11-26 |
北京大学 |
一种共轭亚油酸与吉西他滨连接的前体药物制备方法及其应用
|
DK2833905T3
(en)
|
2012-04-04 |
2018-07-30 |
Halozyme Inc |
Combination therapy with hyaluronidase and a tumor-targeted taxane
|
US8921419B2
(en)
|
2012-05-08 |
2014-12-30 |
Trustees Of Dartmouth College |
Triterpenoids and compositions containing the same
|
US9278912B2
(en)
|
2012-09-10 |
2016-03-08 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
JP6420247B2
(ja)
*
|
2012-11-13 |
2018-11-07 |
ボーイエン セラピューティクス,インコーポレイティド |
ゲムシタビンプロドラッグ及びその使用
|
CN103130854A
(zh)
*
|
2013-01-31 |
2013-06-05 |
华东师范大学 |
维生素e琥珀酸酯化吉西他滨前药及应用
|
CN103159814B
(zh)
*
|
2013-03-28 |
2015-12-23 |
东华大学 |
一种藤黄酸酯类衍生物及其制备方法和用途
|
CN103265594B
(zh)
*
|
2013-03-28 |
2016-05-04 |
东华大学 |
一种藤黄酸酰胺类衍生物及其制备方法和用途
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
US20160250245A1
(en)
*
|
2013-10-21 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections
|
CN105873569B
(zh)
|
2013-11-06 |
2020-07-28 |
芝加哥大学 |
用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
|
WO2015110435A1
(en)
|
2014-01-21 |
2015-07-30 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
LT3096790T
(lt)
|
2014-01-21 |
2019-10-10 |
Janssen Pharmaceutica, N.V. |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
US10463684B2
(en)
|
2014-01-29 |
2019-11-05 |
Board Of Regents, The Uneversety Of Texas System |
Nucleobase analogue derivatives and their applications
|
CA2963819A1
(en)
|
2014-10-08 |
2016-04-14 |
Epigenetics Pharma Llc |
Vitamin e-nucleoside prodrugs
|
JP7090034B2
(ja)
|
2016-05-20 |
2022-06-23 |
ザ ユニバーシティ オブ シカゴ |
化学療法、標的療法、光線力学療法、免疫療法及びそれらの任意の組み合わせのためのナノ粒子
|
CN111194232B
(zh)
|
2017-08-02 |
2023-01-31 |
芝加哥大学 |
纳米级金属有机层和金属有机纳米片
|
BR112020015745A2
(pt)
|
2018-02-02 |
2020-12-08 |
Maverix Oncology, Inc. |
Conjugados de fármacos de moléculas pequenas de monofosfato de gemcitabina
|
US20210238214A1
(en)
*
|
2018-04-26 |
2021-08-05 |
NanoMed Holdings Pty Ltd |
Gemcitabine amphiphile prodrugs
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
MA53140A
(fr)
|
2018-06-29 |
2021-05-19 |
Shanghai Changchengyiyaokeji Company Ltd |
Promédicaments contenant du phosphore de gemcitabine
|
CN110054659B
(zh)
*
|
2019-05-05 |
2020-09-11 |
中国医学科学院医药生物技术研究所 |
提高药物抗肿瘤活性的方法
|
EP3980541A1
(en)
|
2019-06-04 |
2022-04-13 |
Apterna Limited |
Aptamers against transferrin receptor (tfr)
|
GB202019692D0
(en)
|
2020-12-14 |
2021-01-27 |
Apterna Ltd |
Aptamer-sirna fusions
|